Dr. Jacqueline French is a professor in the Department of Neurology NYU, in the comprehensive Epilepsy Center, and Director of the Clinical Trials Consortium. She is the former Assistant Dean for Clinical trials at the University of Pennsylvania. Dr. French trained in Neurology at Mount Sinai Hospital in New York, and did her fellowship training in EEG and epilepsy at Mount Sinai hospital and Yale University.
Dr. French has focused her research efforts on development of new therapeutics for epilepsy. She has written many articles, editorials and chapters and has edited two books on this subject, and is the co-director of a bi-annual symposium on trial design and its implications. This symposium is an opportunity for representatives from government (the FDA and the NIH), members of the academic community, and members of the private research community to discuss drug development and determine new strategies. This meeting has led to the implementation of new trial designs, as well as new strategies for the approval of drugs for use in monotherapy. Dr. French has also been active in creating practice parameters, serving on committees of the American Academy of Neurology and the American Epilepsy Society and chairing several practice parameter Task Forces. She is the 2005 recipient of the American Epilepsy Society Service Award. Recently, she chaired an AAN/AES committee that produced two widely quoted guidelines on the use of new antiepileptic drugs. She has also organized a multicenter effort to prospectively evaluate outcome for patients initiated on new antiepileptic drugs. She has served as an ad hoc reviewer for many journals, is supplements editor for Epileptic Disorders, and is the Epilepsy Section Editor of Clinical Neuropharmacology. She has served on the board of the American Epilepsy Society and the American Society of Experimental Therapeutics. In addition, she is the head of the scientific advisory board of the Epilepsy Therapy Development Project, a private group devoted to the development of new epilepsy therapies. She is the current director of the epilepsy course for the American Academy of Neurology. She lectures in the US and internationally on topics related to antiepileptic drug therapeutics. Currently, she serves as co-chair of the International League Against Epilepsy Commission on Therapeutic Strategies.